These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1081909)

  • 1. Complement (C3) receptor-bearing lymphocyte-mediated cytotoxicity and lymphotoxin responses.
    O'Neill P; Mackler BF; Wyde P
    Cell Immunol; 1975 Nov; 20(1):33-41. PubMed ID: 1081909
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic and soluble mediator responses by complement (C3) receptor-bearing lymphocytes from patients with B-cell immunodeficiency diseases.
    Mackler BF; O'Neill P; Mukhopadhyay N; Richie E; Montgomery J
    Clin Immunol Immunopathol; 1976 Nov; 6(3):279-88. PubMed ID: 1086174
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the C3 receptor in antibody-dependent cytotoxicity.
    Gelfand EW
    Transplantation; 1976 Jan; 21(1):73-5. PubMed ID: 1246711
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement-dependent immunoglobulin G receptor function in lymphoid cells.
    Scornik JC
    Science; 1976 May; 192(4239):563-5. PubMed ID: 1257792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosétte formation between human b lymphocytes and zymosan-C3 complexes using different complement sources.
    Kajdacsy-Balla AA; Mendes NF
    J Immunol Methods; 1976; 9(3-4):205-9. PubMed ID: 1082460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors.
    Rothman IK; Gelfand JA; Fauci AS; Frank MM
    J Immunol; 1975 Nov; 115(5):1312-5. PubMed ID: 1100727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte.
    Kramer SL; Granger GA
    Cell Immunol; 1975 Jan; 15(1):57-68. PubMed ID: 1078544
    [No Abstract]   [Full Text] [Related]  

  • 9. Assay for the two different types of lymphocyte complement receptors.
    Ross GD; Polley MJ
    Scand J Immunol; 1976 Jun; Suppl 5():99-111. PubMed ID: 1053233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent lymphocyte-mediated cytotoxicity (Ab-LMC), definition of the "K cell" in the rat.
    Garovoy MR; Strom TB; Gribik M; Carpenter CB
    Transplantation; 1976 Oct; 22(4):367-73. PubMed ID: 1086539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions of anti-human brain serum with human lymphocyte subpopulations.
    Stratton JA; Byfield PE
    Cell Immunol; 1977 Jan; 28(1):1-14. PubMed ID: 318927
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro immunological characteristics of lymphoid cells derived from owl monkeys infected with Herpesvirus saimiri.
    Wallen WC; Neubauer RH; Rabin H
    J Med Primatol; 1974; 3(1):41-53. PubMed ID: 4209326
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads.
    Huber Ch; Wigzell H
    Eur J Immunol; 1976 Jun; 5(6):432-5. PubMed ID: 1086242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
    Kramer SL; Granger GA
    J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway.
    Theofilopoulos AN; Perrin LH
    Science; 1977 Mar; 195(4281):878-80. PubMed ID: 402691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes.
    Logue GL; Cohen HJ
    J Clin Invest; 1977 Nov; 60(5):1159-64. PubMed ID: 908758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.
    Budzko DB; Lachmann PJ; McConnell I
    Cell Immunol; 1976 Mar; 22(1):98-109. PubMed ID: 1277295
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptococcal preparation as an activator of host-mediated immune response: cellular immunity and alternate pathway of complement.
    Kondo M; Ikezaki M; Imanishi H; Nishigaki I; Hosokawa K
    Gan; 1975 Dec; 66(6):675-8. PubMed ID: 1225721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.